Biotech giant Bayer last week signed an exclusive licensing agreement with Pairwise, a genetic-based food startup, to develop and market its CRISPR-edited mustard greens, modified to be less bitter. Critics say the products haven’t been evaluated for health or environmental risks and could contain toxins or allergens.